Benefits of available ART greater for women than men in South Africa, with many men not engaging with care

Mass HIV treatment and sex disparities in life expectancy: demographic surveillance in rural South Africa.

Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, Tanser F, Pillay D, Bärnighausen T. PLoS Med. 2015 Nov 24;12(11):e1001905. doi: 10.1371/journal.pmed.1001905. eCollection 2015.

Background: Women have better patient outcomes in HIV care and treatment than men in sub-Saharan Africa. We assessed - at the population level - whether and to what extent mass HIV treatment is associated with changes in sex disparities in adult life expectancy, a summary metric of survival capturing mortality across the full cascade of HIV care. We also determined sex-specific trends in HIV mortality and the distribution of HIV-related deaths in men and women prior to and at each stage of the clinical cascade.

Methods and findings: Data were collected on all deaths occurring from 2001 to 2011 in a large population-based surveillance cohort (52 964 women and 45 688 men, ages 15 y and older) in rural KwaZulu-Natal, South Africa. Cause of death was ascertained by verbal autopsy (93% response rate). Demographic data were linked at the individual level to clinical records from the public sector HIV treatment and care program that serves the region. Annual rates of HIV-related mortality were assessed for men and women separately, and female-to-male rate ratios were estimated in exponential hazard models. Sex-specific trends in adult life expectancy and HIV-cause-deleted adult life expectancy were calculated. The proportions of HIV deaths that accrued to men and women at different stages in the HIV cascade of care were estimated annually. Following the beginning of HIV treatment scale-up in 2004, HIV mortality declined among both men and women. Female adult life expectancy increased from 51.3 y (95% CI 49.7, 52.8) in 2003 to 64.5 y (95% CI 62.7, 66.4) in 2011, a gain of 13.2 y. Male adult life expectancy increased from 46.9 y (95% CI 45.6, 48.2) in 2003 to 55.9 y (95% CI 54.3, 57.5) in 2011, a gain of 9.0 y. The gap between female and male adult life expectancy doubled, from 4.4 y in 2003 to 8.6 y in 2011, a difference of 4.3 y (95% CI 0.9, 7.6). For women, HIV mortality declined from 1.60 deaths per 100 person-years (95% CI 1.46, 1.75) in 2003 to 0.56 per 100 person-years (95% CI 0.48, 0.65) in 2011. For men, HIV-related mortality declined from 1.71 per 100 person-years (95% CI 1.55, 1.88) to 0.76 per 100 person-years (95% CI 0.67, 0.87) in the same period. The female-to-male rate ratio for HIV mortality declined from 0.93 (95% CI 0.82-1.07) in 2003 to 0.73 (95% CI 0.60-0.89) in 2011, a statistically significant decline (p = 0.046). In 2011, 57% and 41% of HIV-related deaths occurred among men and women, respectively, who had never sought care for HIV in spite of the widespread availability of free HIV treatment. The results presented here come from a poor rural setting in southern Africa with high HIV prevalence and high HIV treatment coverage; broader generalizability is unknown. Additionally, factors other than HIV treatment scale-up may have influenced population mortality trends.

Conclusions: Mass HIV treatment has been accompanied by faster declines in HIV mortality among women than men and a growing female-male disparity in adult life expectancy at the population level. In 2011, over half of male HIV deaths occurred in men who had never sought clinical HIV care. Interventions to increase HIV testing and linkage to care among men are urgently needed.

Abstract [1] Full-text [free] access [2]

Editor’s notes: In South Africa and many other sub-Saharan African countries, mass treatment with anti-retroviral therapy (ART) has led to dramatic decreases in mortality and increases in life expectancy. South Africa has provided ART free-of-charge since 2004, but HIV-associated diseases remain the leading cause of death in adults. This paper uses clinical and demographic data from a longitudinal cohort in a rural area of KwaZulu-Natal in South Africa to assess how gender differences in adult life expectancy and HIV-associated mortality changed between 2001 and 2011.

Overall life expectancy increased for both genders since 2004 with the effect significantly greater for females than males. The gender differential in life expectancy over the period 2004-2011 increased from 4.4 to 8.6 years. The analysis illustrates that this decrease was due to decreases in HIV-associated mortality rates, as HIV-cause-deleted life expectancy (i.e. life expectancy that would have occurred in the absence of HIV) remained constant over this period.

This study emphasizes the HIV treatment gap for men, with approximately half of all HIV-associated deaths in this population occurred among men who had never sought care. Mortality for men was significantly higher than that for women at each stage of the treatment cascade.

Although this study draws on data from one rural setting, many of the underlying characteristics reflect those seen in many other rural areas of the country. Further work is necessary to understand the underlying social and cultural factors that underlie these findings which could then lead to the development of programmes designed to address them. Such cross-disciplinary research which engages with people designing and implementing HIV programmes will need to be significantly enhanced over the coming decade in order to meet the UNAIDS 90:90:90 targets.

Africa [8]
South Africa [9]
  • [10]